Teens are being prescribed Ozempic more than ever before — and some doctors are worried about what the trend could mean.

The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...

Medicamento e demais fármacos liberados integram nova diretriz para tratamento da doença no Brasil; avaliação médica continua ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide ...

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

Valores reduzidos passam a valer nesta segunda-feira, 2, em plataformas de e-commerce e lojas físicas de grandes redes de ...

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

Shares of Ozempic and Wegovy manufacturer Novo Nordisk (NYSE: NVO) reacted positively to the news and are up 4.9% as of 10:20 a.m. ET. America has caught Ozempic fever, and 25% of Novo Nordisk's ...

America has caught Ozempic fever, and 25% of Novo Nordisk's assets are located here in the U.S., where the company produces much of its drugs. The company also announced last year that it would ...

It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy. Competitors are nipping at its heels, cheaper knockoffs have been eating into ...

In recent months, a staggering number of women, particularly on social media, have been sharing their experiences with Ozempic, a drug that was originally developed to treat type 2 diabetes.